• Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Rating of "Moderate Buy" by Brokerages

    ソース: Buzz FX / 03 3 2025 04:12:13   America/Chicago


    Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Rating of "Moderate Buy" by Brokerages Written by MarketBeat March 3, 2025 Share Link copied to clipboard. Esperion Therapeutics, Inc. ( NASDAQ:ESPR - Get Free Report ) has received a
    Read more...
シェアする